Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose adenosine as a first-line regimen for stress cardiac MRI
TCTR20250521004Phase 2Recruiting
- Sponsor
- Thai Red Cross Society
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of adenosine in cardiac ischemia (2 arms), sponsored by Thai Red Cross Society. Primary endpoint: Diagnostic adequacy of stress cardiac MRI with high-dose adenosine. Started Sep 2025; status: recruiting.
02
Drugs
adenosine
03
Conditions
cardiac ischemia
Beyond the preview
Go deeper on TCTR20250521004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250521004.